← FDA DRUG APPROVALS

FDA ANDA · ANDA217828

MYCOPHENOLATE MOFETIL

Sponsor: AUROBINDO PHARMA LTD

APPLICATION
ANDA217828
TYPE
ANDA
ORIGINAL APPROVAL
2024-01-05
LATEST ACTION
2026-07-29
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

MYCOPHENOLATE MOFETILPrescription
MYCOPHENOLATE MOFETIL 250MG · CAPSULE · ORAL

Approval history

2026-07-29REMS · Supplement 5AP
2026-01-14Labeling · Supplement 3 · standardAP
2024-08-13REMS · Supplement 1AP
2024-01-05UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →